StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.10−0.19 (-3.02%)

Close on Nov 18, 2026Market cap $817.84MP/E –Yield –

Immatics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Immatics's market cap was $818.51M on Nov 11, 2026, against $1.14B a year earlier. Over the last 5 years it ranged from $352.79M to $1.41B, with a median of $732.97M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$818.51M-27.0%
2025Dec 31, 2025$1.12B+95.8%
2024Dec 31, 2024$572.69M-21.0%
2023Dec 29, 2023$724.73M+32.3%
2022Dec 30, 2022$547.97M-15.1%
2021Dec 31, 2021$645.14M+80.7%
2020Dec 31, 2020$357.08M+3.8%
2019Dec 31, 2019$344.18M–

More Immatics figures

See a number that looks wrong?